Evidence map›Paper›PMID 27834155›Full record

ArticleGenetics research2016

Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions.

Anna Keravnou, Marios Ioannides, Kyriakos Tsangaras, Charalambos Loizides, Michael D Hadjidaniel, Elisavet A Papageorgiou, Skevi Kyriakou, Pavlos Antoniou, Petros Mina, Achilleas Achilleos and 5 more

Abstract read
In one paragraph

Article in Genetics research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anna KeravnouTranslational Genetics Team,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.
Marios IoannidesNIPD Genetics,Nicosia,Cyprus.
Kyriakos TsangarasNIPD Genetics,Nicosia,Cyprus.
Charalambos LoizidesNIPD Genetics,Nicosia,Cyprus.
Michael D HadjidanielTranslational Genetics Team,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.
Elisavet A PapageorgiouTranslational Genetics Team,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.
Skevi KyriakouTranslational Genetics Team,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.
Pavlos AntoniouNIPD Genetics,Nicosia,Cyprus.
Petros MinaNIPD Genetics,Nicosia,Cyprus.
Achilleas AchilleosNIPD Genetics,Nicosia,Cyprus.
Maria NeofytouTranslational Genetics Team,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.
Elena KypriTranslational Genetics Team,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.
Carolina SismaniDepartment of Cytogenetics and Genomics,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.
George KoumbarisTranslational Genetics Team,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.
Philippos C PatsalisTranslational Genetics Team,The Cyprus Institute of Neurology and Genetics,Nicosia,Cyprus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA methylation is an epigenetic marker that has been shown to vary significantly across different tissues. Taking advantage of the methylation differences between placenta-derived cell-free DNA and maternal blood, several groups employed different approaches for the discovery of fetal-specific biomarkers. The aim of this study was to analyse whole-genome fetal and maternal methylomes in order to identify and confirm the presence of differentially methylated regions (DMRs). We have initially utilized methylated DNA immunoprecipitation (MeDIP) and next-generation sequencing (NGS) to identify genome-wide DMRs between chorionic villus sampling (CVS) and female non-pregnant plasma (PL) and peripheral blood (WBF) samples. Next, using specific criteria, 331 fetal-specific DMRs were selected and confirmed in eight CVS, eight WBF and eight PL samples by combining MeDIP and in-solution targeted enrichment followed by NGS. Results showed higher enrichment in CVS samples as compared to both WBF and PL samples, confirming the distinct methylation levels between fetal and maternal DNA for the selected DMRs. We have successfully implemented a novel approach for the discovery and confirmation of a significant number of fetal-specific DMRs by combining for the first time MeDIP and in-solution targeted enrichment followed by NGS. The implementation of this double-enrichment approach is highly efficient and enables the detailed analysis of multiple DMRs by targeted NGS. Also, this is, to our knowledge, the first reported application of MeDIP on plasma samples, which leverages the implementation of our enrichment methodology in the detection of fetal abnormalities in maternal plasma.

Indexed as

DNA MethylationGenome, HumanBiomarkersChorionic Villi SamplingDNAEpigenesis, GeneticFemaleFetal DiseasesFetusHigh-Throughput Nucleotide SequencingHumansImmunoprecipitationMaternal Serum Screening TestsPlacentaPregnancyPregnancy ComplicationsBiomarkersDNA

Identifiers

PMID27834155
PMCPMC6865150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.